1. Home
  2. STBA vs ANIP Comparison

STBA vs ANIP Comparison

Compare STBA & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo S&T Bancorp Inc.

STBA

S&T Bancorp Inc.

N/A

Current Price

$51.03

Market Cap

1.8B

Sector

Finance

ML Signal

N/A

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

N/A

Current Price

$71.61

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STBA
ANIP
Founded
1902
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
1995
1999

Fundamental Metrics

Financial Performance
Metric
STBA
ANIP
Price
$51.03
$71.61
Analyst Decision
Hold
Buy
Analyst Count
7
8
Target Price
$54.17
★ $103.38
AVG Volume (30 Days)
185.3K
★ 371.8K
Earning Date
10-22-2026
11-05-2026
Dividend Yield
★ 2.91%
N/A
EPS Growth
2.35
★ 419.23
EPS
3.04
★ 3.86
Revenue
N/A
★ $206,547,000.00
Revenue This Year
$4.42
$24.30
Revenue Next Year
$3.67
$10.96
P/E Ratio
★ $16.69
$18.45
Revenue Growth
N/A
★ 2.47
52 Week Low
$36.95
$67.38
52 Week High
$53.58
$87.76

Technical Indicators

Market Signals
Indicator
STBA
ANIP
Relative Strength Index (RSI) 53.12 51.28
Support Level $50.43 $71.45
Resistance Level $53.54 $74.86
Average True Range (ATR) 1.18 2.51
MACD -0.04 0.11
Stochastic Oscillator 26.50 52.78

Price Performance

Historical Comparison
STBA
ANIP

About STBA S&T Bancorp Inc.

S&T Bancorp Inc is a financial holding company providing a full range of financial services to individuals and businesses in Pennsylvania and Ohio, including retail and commercial banking products, cash management, and trust and brokerage services. Through its subsidiary, it offers consumer, commercial, and small business banking services, including time and demand deposits, commercial and consumer loans, brokerage and trust services, and manages private investment accounts for individuals and institutions. The company earns revenue mainly from interest on loans and securities and fees for financial services, with net interest income as the principal source of revenue, and incurs expenses for deposits, funding sources, provision for credit losses, and operating costs.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: